LONDON, ENGLAND – 26 October 2009 – A significant step in driving innovation, improving patient care and increasing efficiency in early stage clinical research was taken today with the announcement that two of the UK’s leading institutions - Guy’s and St Thomas’ NHS Foundation Trust and King’s College London - have signed a collaborative agreement with Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide.

As part of the agreement, Quintiles has commissioned a state of the art research facility with 30 beds, for both patients and healthy volunteers involved in research, on the 14th floor of Guy’s Hospital in central London. The facility, to be completed in early 2010, will now be known as the Quintiles Drug Research Unit at Guy’s Hospital. The facility significantly increases Quintiles’ capacity to conduct proof-of-concept programmes that help biopharmaceutical companies develop better medicines faster.

“The biopharmaceutical industry must bring new drugs to market faster and with greater predictability to address declining research and development productivity,” said Eddie Caffrey, Senior Vice President, Global Phase I, Quintiles. “The smartest move is to invest in intelligent, early-stage development because, when done well, it has significant impact on speed and cost of the overall development process.”

A further strength of the collaboration is that it will bring Quintiles physically and professionally closer to academic and medical colleagues in the Academic Health Sciences Centre (AHSC), King’s Health Partners, and its National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre (BRC). The Quintiles Drug Research Unit at Guy’s Hospital will be perfectly positioned next to leading-edge Clinical Research Facilities and a Good Manufacturing Practice (GMP) Pharmacy currently being developed by Guy’s and St Thomas’ and King’s College London to drive forward the translation of science onto the wards -from ‘bench to bedside’ - and will also be adjacent to the home of the BRC’s new Faculty of Translational Medicine.

Ron Kerr, Chief Executive of Guy’s and St Thomas’ NHS Foundation Trust said: “We want to deliver the best possible care to our patients, and we know that aligning clinical service excellence with translational research has been shown to be one of the most effective ways to do this. We’re excited by the potential of this collaboration as it will lead to a smoother and faster clinical trials process, ensuring our patients and local people are amongst the first to benefit from any new discoveries.”

Professor Robert Lechler, Vice-Principal (Health), King’s College London and Director of King’s Health Partners, said: “King’s College London’s important partnership with Quintiles and Guy’s and St Thomas’ NHS Foundation Trust, one of our Academic Health Sciences Centre (AHSC) partners, is exactly the sort of collaboration we expect to see at the heart of King’s Health Partners. Through this collaboration and the significant investments we have already made to develop first class clinical research facilities, we will create a powerful ‘experimental medicine’ hub across four floors of the Guy’s Hospital Tower, allowing us to harness the expertise of our world class scientists and clinicians to drive new discoveries in medicine and clinical treatment.”

The agreement between Quintiles, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London was brokered by King’s Business, the innovation support company for King's College London.

This expansion builds on Quintiles’ existing, industry leading, network of Phase I facilities across Europe, Asia and the US. Its experts and pioneers utilise integrated data platforms comprising technically advanced electronic data capture and reporting to facilitate early go/no-go decision making. This new facility in Guy’s Hospital Tower, is an expansion of Quintiles existing facilities in Newcomen Street.


About Quintiles
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of 23,000 engaged professionals in more than 50 countries around the globe works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant.

About Guy’s and St Thomas’ NHS Foundation Trust
Guy's and St Thomas' provides around ¾ million patient contacts in acute and specialist hospital services every year. As one of the biggest NHS Trusts in the UK, it employs over 9,000 staff. The Trust works in partnership with the Schools of Medicine, Dentistry, Nursing and Biomedical Sciences of King's College London and other Higher Education Institutes to deliver high quality education and research. Website:

About King’s College London
King’s College London is one of the top 25 universities in the world (Times Higher Education 2008) and the fourth oldest in England. A research-led university based in the heart of London, King’s has 19,700 students from more than 150 countries, and 5,400 employees. An investment of over £500 million has been made in the redevelopment of its estate in recent years

About King’s Health Partners
King's College London and Guy's and St Thomas', King's College Hospital and South London and Maudsley NHS Foundation Trusts are part of King’s Health Partners.

King’s Health Partners Academic Health Sciences Centre (AHSC) is a pioneering global collaboration between one of the world’s leading research-led universities and three of London’s most successful NHS Foundation Trusts, including leading teaching hospitals and comprehensive mental health services.

The driving purpose of King's Health Partners is to continually seek and bring about swifter and more effective improvements in health and well-being for patients in London and people everywhere. Combining the best of basic and translational research, clinical excellence and world-class teaching to deliver groundbreaking advances in physical and mental healthcare.
For more information, visit: